TransMedics Group Insider Trades
NASDAQ: TMDXHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
Market open · Delayed 15 min · as of Oct 9, 3:13 PM ET
Last 12 months
- Purchases
- 2 · $1.11M
- Sales
- 12 · $4.87M
- Shares bought / sold
- 10.11K / 38.89K
- Net activity
- Net selling $3.8 million
TransMedics Group insider activity
Over the last 12 months, TransMedics Group insiders reported 35 transactions on SEC Form 4: 2 open-market purchases and 12 sales. Insiders bought $1.1 million and sold $4.9 million worth of stock, for net insider selling of $3.8 million. The largest seller was Hernandez Gerardo, with $1.2 million in reported sales.
The most recent filing shows Weill David (Director) buying 1,336 shares at $81.63 on Sep 11, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TMDX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TMDX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 11, 2026 | Weill DavidDirector | Buy | 1,336 | $109.06K | Form 4 |
| Aug 17, 2026 | TOBIN JAMES RDirector | Gift | 18,000 | — | Form 4 |
| Jul 10, 2026 | Hassanein Waleed HPresident & CEO | Award | 49,669 | — | Form 4 |
| Jul 10, 2026 | Hernandez GerardoChief Financial Officer | Award | 17,246 | — | Form 4 |
| Jul 10, 2026 | Corcoran NicholasSee remarks | Award | 11,727 | — | Form 4 |
| Jun 15, 2026 | Gunderson Thomas J.Director | Sale | 9,624 | $722.38K | Form 4 |
| Jun 15, 2026 | Gunderson Thomas J.Director | Option exercise | 19,285 | $42.62K | Form 4 |
| May 20, 2026 | TOBIN JAMES RDirector | Award | 2,922 | — | Form 4 |
| May 20, 2026 | Basile Edward MDirector | Award | 2,922 | — | Form 4 |
| May 20, 2026 | Gunderson Thomas J.Director | Award | 2,922 | — | Form 4 |
| May 20, 2026 | Kania EdwinDirector | Award | 2,922 | — | Form 4 |
| May 20, 2026 | RAINES MERILEEDirector | Award | 2,922 | — | Form 4 |
| May 20, 2026 | Weill DavidDirector | Award | 2,922 | — | Form 4 |
| May 20, 2026 | Lovell StephanieDirector | Award | 2,922 | — | Form 4 |
| May 19, 2026 | Forsyth Matthew S.See Remarks | Award | 15,409 | — | Form 4 |
| Mar 4, 2026 | Hernandez GerardoChief Financial Officer | Sale | 5,912 | $870.31K | Form 4 |
| Mar 4, 2026 | Hernandez GerardoChief Financial Officer | Option exercise | 5,912 | $412.89K | Form 4 |
| Mar 4, 2026 | Hernandez GerardoChief Financial Officer | Sale | 1,324 | $194.91K | Form 4 |
| Mar 4, 2026 | Hernandez GerardoChief Financial Officer | Option exercise | 1,324 | $102.11K | Form 4 |
| Mar 4, 2026 | Lovell StephanieDirector | Sale | 1,193 | $178.50K | Form 4 |
| Mar 4, 2026 | Weill DavidDirector | Sale | 3,571 | $524.29K | Form 4 |
| Mar 4, 2026 | Weill DavidDirector | Option exercise | 3,571 | $50.71K | Form 4 |
| Mar 2, 2026 | Corcoran NicholasSee remarks | Sale | 2,966 | $412.63K | Form 4 |
| Mar 2, 2026 | Ranganath Anil P.See remarks | Sale | 864 | $120.20K | Form 4 |
| Mar 2, 2026 | Hernandez GerardoChief Financial Officer | Sale | 375 | $52.17K | Form 4 |
| Feb 18, 2026 | Cecere GiovanniChief Commercial Officer | Award | 11,082 | — | Form 4 |
| Jan 23, 2026 | Corcoran NicholasSee remarks | Tax withholding | 984 | $133.14K | Form 4 |
| Dec 4, 2025 | Hernandez GerardoChief Financial Officer | Sale | 920 | $128.45K | Form 4 |
| Dec 3, 2025 | Weill DavidDirector | Sale | 5,000 | $693.20K | Form 4 |
| Dec 3, 2025 | Weill DavidDirector | Option exercise | 5,000 | $71.00K | Form 4 |
| Nov 25, 2025 | Ranganath Anil P.See remarks | Sale | 3,000 | $435.66K | Form 4 |
| Nov 25, 2025 | Ranganath Anil P.See remarks | Option exercise | 3,000 | $281.64K | Form 4 |
| Nov 17, 2025 | Hassanein Waleed HPresident & CEO | Buy | 8,775 | $1.00M | Form 4 |
| Oct 29, 2025 | Basile Edward MDirector | Sale | 4,142 | $540.32K | Form 4 |
| Oct 29, 2025 | Basile Edward MDirector | Option exercise | 4,142 | $2.90K | Form 4 |
| Aug 7, 2025 | Hassanein Waleed HPresident & CEO | Buy | 1,858 | $217.11K | Form 4 |
| Aug 7, 2025 | Hassanein Waleed HPresident & CEO | Buy | 6,617 | $768.10K | Form 4 |
| Aug 6, 2025 | Hassanein Waleed HPresident & CEO | Buy | 8,400 | $996.91K | Form 4 |
| Aug 4, 2025 | Basile Edward MDirector | Sale | 4,143 | $519.99K | Form 4 |
| Aug 4, 2025 | Basile Edward MDirector | Option exercise | 4,143 | $2.90K | Form 4 |
| Jun 9, 2025 | Ranganath Anil P.See remarks | Sale | 686 | $95.90K | Form 4 |
| May 27, 2025 | Basile Edward MDirector | Sale | 5,000 | $632.25K | Form 4 |
| May 27, 2025 | Basile Edward MDirector | Option exercise | 5,000 | $3.50K | Form 4 |
| May 23, 2025 | Weill DavidDirector | Sale | 732 | $90.68K | Form 4 |
| May 22, 2025 | Weill DavidDirector | Award | 2,134 | — | Form 4 |
| May 22, 2025 | Gunderson Thomas JamesDirector | Award | 2,134 | — | Form 4 |
| May 22, 2025 | Lovell StephanieDirector | Award | 2,134 | — | Form 4 |
| May 22, 2025 | Basile Edward MDirector | Award | 2,134 | — | Form 4 |
| May 22, 2025 | KANIA EDWIN M JRDirector | Award | 2,134 | — | Form 4 |
| May 22, 2025 | RAINES MERILEEDirector | Award | 2,134 | — | Form 4 |
| May 22, 2025 | TOBIN JAMES RDirector | Award | 2,134 | — | Form 4 |
| May 9, 2025 | Basile Edward MDirector | Sale | 6,000 | $693.78K | Form 4 |
| May 9, 2025 | Basile Edward MDirector | Option exercise | 6,000 | $4.20K | Form 4 |
| Mar 3, 2025 | Khayal Tamer IChief Commercial Officer | Sale | 2,407 | $183.97K | Form 4 |
| Feb 25, 2025 | Hassanein Waleed HPresident & CEO | Award | 59,781 | — | Form 4 |
| Feb 24, 2025 | Hernandez GerardoChief Financial Officer | Award | 3,521 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4